Prelude Capital Management’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
Other funds holding ULBI
VWA
VCM
THC
RC
Prelude Capital Management's ULBI Position: Q1 2026 in Review
Prelude Capital Management sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 11,641 shares — an estimated $66.6K sold.
Prelude Capital Management first reported a position in ULBI in Q2 2017 and held it in 14 quarters. The position peaked at $143K in Q2 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.
- Prelude Capital Management reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 11,641 Ultralife shares in Q1 2026, an estimated $66.6K.
- Prelude Capital Management first reported a position in Ultralife in Q2 2017 and held it in 14 quarters.
- Prelude Capital Management's Ultralife position peaked at $143K in Q2 2024.
- 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.